Richard A. Hammett - 01 Jan 2023 Form 3 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3
Filing time
11 Jan 2023, 17:43:34 UTC
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCA Common Stock 7,709 01 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCA Restricted Stock Units 01 Jan 2023 Common Stock 598 Direct F1
holding HCA Restricted Stock Units 01 Jan 2023 Common Stock 1,200 Direct F1, F2
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 13,850 $104.86 Direct F3
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 9,160 $173.12 Direct F4
holding HCA Stock Appreciation Right 01 Jan 2023 Common Stock 6,930 $236.61 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.
F2 The restricted stock units vest in two equal annual installments beginning January 29, 2023.
F3 The stock appreciation rights vest in four equal annual installments beginning on May 1, 2021.
F4 The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.
F5 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023.